23-Apr-2026
SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026
PRNewswire (Tue, 21-Apr 8:00 AM ET)
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results
PRNewswire (Tue, 3-Mar 6:45 AM ET)
SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference
PRNewswire (Wed, 25-Feb 8:00 AM ET)
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026
PRNewswire (Tue, 17-Feb 8:00 AM ET)
PRNewswire (Tue, 10-Feb 9:22 AM ET)
Market Chameleon (Mon, 12-Jan 3:43 AM ET)
Market Chameleon (Thu, 16-Oct 3:56 AM ET)
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Sophia Genetics SA - trades on the NASDAQ stock market under the symbol SOPH.
As of April 23, 2026, SOPH stock price declined to $4.87 with 69,240 million shares trading.
SOPH has a beta of 1.18, meaning it tends to be more sensitive to market movements. SOPH has a correlation of 0.10 to the broad based SPY ETF.
SOPH has a market cap of $323.56 million. This is considered a Small Cap stock.
Last quarter Sophia Genetics SA - reported $22 million in Revenue and -$.28 earnings per share. This beat revenue expectation by $819,500 and missed earnings estimates by -$.08.
In the last 3 years, SOPH traded as high as $7.37 and as low as $2.13.
The top ETF exchange traded funds that SOPH belongs to (by Net Assets): ONEQ, MEDI.
SOPH has outperformed the market in the last year with a return of +59.2%, while the SPY ETF gained +33.7%. However, in the most recent history, SOPH shares have underperformed the stock market with its stock returning -9.1% in the last 3 month period and +3.0% for the last 2 week period, while SPY has returned +3.0% and +4.2%, respectively.
SOPH support price is $4.93 and resistance is $5.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SOPH shares will trade within this expected range on the day.